HEXTEND 6% Hetastarch in Lactated Electrolyte Injection, 500 mL, Rx only , MANUF Supply Disruption — Hospira Inc. (Moderate Risk —
HEXTEND 6% Hetastarch in Lactated Electrolyte Injection, 500 mL, Rx only , MANUF Supply Disruption — Hospira Inc. (Moderate Risk — is one of 9,000 drug supply records in the DrugSupply dataset. Key details — Drug name: HEXTEND 6% Hetastarch in Lactated Electrolyte Injection, 500 mL, Rx only , MANUF; Manufacturer: Hospi
| Drug name | HEXTEND 6% Hetastarch in Lactated Electrolyte Injection, 500 mL, Rx only , MANUF |
|---|---|
| Manufacturer | Hospira Inc. |
| Recall/Disruption reason | Lack of Assurance of Sterility: There is the potential for the solution to leak from the seal of the fill tube to the ba |
| Risk classification | Moderate Risk — Temporary Health Consequence |
| Status | Terminated |
| Record type | Enforcement/Recall |
| Recall number | D-184-2013 |
| Initiation date | 20121022 |
| Quantity affected | 11,412 bags |
| Dosage form | Drugs |
🔍 Search all drug supply records →
$1199/mo
Try DrugSupply →